These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid. Casey P, Glauser M. Eur J Clin Microbiol; 1983 Dec; 2(6):541-7. PubMed ID: 6607834 [Abstract] [Full Text] [Related]
17. Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo. Boon RJ, Beale AS, Sutherland R. Antimicrob Agents Chemother; 1986 May; 29(5):838-44. PubMed ID: 3524431 [Abstract] [Full Text] [Related]
18. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms. Hsueh PR, Chang SC, Chen YC, Hsu LY, Luh KT, Hsieh WC. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000 [Abstract] [Full Text] [Related]
19. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents. Downes J, Andrew JH. Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597 [Abstract] [Full Text] [Related]
20. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group. Bourgault AM, Lamothe F. J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324 [Abstract] [Full Text] [Related] Page: [Next] [New Search]